Yazji Salim 4
4 · Oncternal Therapeutics, Inc. · Filed Jan 5, 2024
Insider Transaction Report
Form 4
Yazji Salim
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2024-01-03$0.50/sh−19,742$9,794→ 128,635 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.